Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-692 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-692, RRID:AB_10127708
- Product name
- Mouse Monoclonal MGMT Antibody
- Antibody type
- Monoclonal
- Description
- MGMT
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.5 ml
- Storage
- Store at 4C. Do not freeze.
Submitted references Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma.
Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner.
Major differences between tumor and normal human cell fates after exposure to chemotherapeutic monofunctional alkylator.
MGMT immunoexpression in growth hormone-secreting pituitary adenomas and its correlation with Ki-67 labeling index and cytokeratin distribution pattern.
MGMT immunoexpression in adamantinomatous craniopharyngiomas.
High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.
Rabé M, Dumont S, Álvarez-Arenas A, Janati H, Belmonte-Beitia J, Calvo GF, Thibault-Carpentier C, Séry Q, Chauvin C, Joalland N, Briand F, Blandin S, Scotet E, Pecqueur C, Clairambault J, Oliver L, Perez-Garcia V, Nadaradjane A, Cartron PF, Gratas C, Vallette FM
Cell death & disease 2020 Jan 6;11(1):19
Cell death & disease 2020 Jan 6;11(1):19
Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner.
Palmieri D, Duchnowska R, Woditschka S, Hua E, Qian Y, Biernat W, Sosińska-Mielcarek K, Gril B, Stark AM, Hewitt SM, Liewehr DJ, Steinberg SM, Jassem J, Steeg PS
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 May 15;20(10):2727-39
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 May 15;20(10):2727-39
Major differences between tumor and normal human cell fates after exposure to chemotherapeutic monofunctional alkylator.
Gupte M, Tuck AN, Sharma VP, Williams KJ
PloS one 2013;8(9):e74071
PloS one 2013;8(9):e74071
MGMT immunoexpression in growth hormone-secreting pituitary adenomas and its correlation with Ki-67 labeling index and cytokeratin distribution pattern.
Zuhur SS, Tanik C, Karaman Ö, Velet S, Çil E, Öztürk FY, Özkayalar H, Müslüman AM, Altuntaş Y
Endocrine 2011 Oct;40(2):222-7
Endocrine 2011 Oct;40(2):222-7
MGMT immunoexpression in adamantinomatous craniopharyngiomas.
Zuhur SS, Müslüman AM, Tanık C, Karaman O, Oztürk FY, Ozderya A, Ozkayalar H, Aydın Y, Altuntaş Y
Pituitary 2011 Dec;14(4):323-7
Pituitary 2011 Dec;14(4):323-7
High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.
Takeshita A, Inoshita N, Taguchi M, Okuda C, Fukuhara N, Oyama K, Ohashi K, Sano T, Takeuchi Y, Yamada S
European journal of endocrinology 2009 Oct;161(4):553-9
European journal of endocrinology 2009 Oct;161(4):553-9
No comments: Submit comment
No validations: Submit validation data